Recruiting Lupus Studies in Great Neck
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects With Refractory Lupus Nephritis...
About Lupus Clinical Trials in Great Neck
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Great Neck, NY. These studies are seeking a combined 130 participants. Research is being sponsored by Amgen, Kyverna Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Great Neck — FAQ
Are there lupus clinical trials in Great Neck?
Yes, there are 2 lupus clinical trials currently recruiting in Great Neck, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Great Neck?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Great Neck research site will contact you about next steps.
Are clinical trials in Great Neck free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Great Neck studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Great Neck are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov